Similarity and Difference in Characteristics of Two Diseases, SFTS and CCHF, and Their Causative Agents
Author:
Shimojima Masayuki
Publisher
Springer Singapore
Reference138 articles.
1. Altamura LA, Bertolotti-Ciarlet A, Teigler J, Paragas J, Schmaljohn CS, Doms RW (2007) Identification of a novel C-terminal cleavage of Crimean-Congo hemorrhagic fever virus PreGN that leads to generation of an NSM protein. J Virol 81(12):6632–6642
2. Andersson I, Lundkvist A, Haller O, Mirazimi A (2006) Type I interferon inhibits Crimean-Congo hemorrhagic fever virus in human target cells. J Med Virol 78(2):216–222
3. Antoniadis A, Casals J (1982) Serological evidence of human infection with Congo-Crimean hemorrhagic fever virus in Greece. Am J Trop Med Hyg 31(5):1066–1067
4. Ascioglu S, Leblebicioglu H, Vahaboglu H, Chan KA (2011) Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis. J Antimicrob Chemother 66(6):1215–1222
5. Atkinson B, Chamberlain J, Logue CH, Cook N, Bruce C, Dowall SD, Hewson R (2012a) Development of a real-time RT-PCR assay for the detection of Crimean-Congo hemorrhagic fever virus. Vector Borne Zoonotic Dis 12(9):786–793